Clinical trial Recruiting at 1 site Interventional Ages 18 Months and up Men only

Using HIFEM technology to treat urinary incontinence in men after prostate surgery

Official title: To Investigate the Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of Stress Urinary Incontinence Compared With Standard of Care in Chinese Men Who Had Undergone Robotic Radical Prostatectomy

Run by Chinese University of Hong Kong · NCT06589869 · Data updated 2026-11-12

This study is testing if a new HIFEM treatment can help men who have had prostate surgery with their urinary incontinence better than standard care.

More Prostatectomy trials

Quick facts

Study typeInterventional
Ages18 Months and up
SexMen only
Enrollment184 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shatin)
StatusRecruiting
StartedJuly 29, 2022
Main results expectedJune 30, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT06589869 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese men who have undergone robotic radical prostatectomy and are experiencing stress urinary incontinence.

Probably not a fit

Patients with pre-existing stress urinary incontinence or those with conditions contraindicated for electromagnetic therapy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness and safety of High-Intensity Focused Electromagnetic (HIFEM) Technology in treating stress urinary incontinence in Chinese men who have undergone robotic radical prostatectomy. Participants will be randomly assigned to receive either HIFEM-assisted pelvic floor muscle training or standard care. The study aims to determine if the HIFEM technology provides better outcomes compared to traditional methods. The trial will include a one-hour pad test to assess urinary incontinence levels.

Why it matters

Potential benefit: If successful, this treatment could significantly improve urinary control and quality of life for men suffering from incontinence after prostate surgery.

How similar studies have gone: While the use of HIFEM technology is gaining interest, this specific application in post-prostatectomy urinary incontinence is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergone robotic radical prostatectomy
* Able to carry out 1-hour pad test
* Voluntary participation and signing of the informed consent form

Exclusion Criteria:

* Pre-existing stress urinary incontinence
* Post-void residual urine greater than 200ml
* Active urinary tract infection
* Urethral or bladder fistula
* History of pelvic irradiation
* Neurological condition (Spinal cord problems, stroke with poor neurological recovery, epilepsy, Parkinson disease, multiple sclerosis)
* Previous surgery for SUI
* Concurrent medication with diuretics, serotonin-norepinephrine reuptake inhibitors or any other medication known to worsen incontinence
* Condition contraindicated for electromagnetic therapy i.e. Arrhythmia, on a pacemaker or implanted metallic device; Coagulopathy or on anticoagulant

Where it's running

  • Prince of Wales Hospital
    Shatin, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.